Kizito Kyeremateng, Speaker at Dermatology Conferences
Kizito Kyeremateng
Sun Pharmaceutical Industries, United States
2026
Poster Presentation (Virtual)
Title : Efficacy of deuruxolitinib in patients with severe alopecia areata by baseline nail involvement: Pooled post hoc analysis of the THRIVE-AA1 and THRIVE-AA2 phase 3 trials
2026
Poster Presentation (Virtual)
Title : Maintenance of hair regrowth following dose reduction or discontinuation of deuruxolitinib in patients with severe alopecia areata: A phase 2 randomized study